Mariner Independent Advisor Network’s AbbVie ABBV Stock Holding History

Mariner Independent Advisor Network’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$6.17M	Sell	45,968 -2,164	-4%	-$311K	0.27%	88
2022 Q2	$7.35M	Buy	48,132 +11,281	+31%	+$1.72M	0.31%	79
2022 Q1	$5.96M	Buy	36,851 +8,339	+29%	+$1.21M	0.23%	109
2021 Q4	$3.86M	Sell	28,512 -4,653	-14%	-$550K	0.18%	128
2021 Q3	$3.58M	Buy	33,165 +8,080	+32%	+$923K	0.17%	145
2021 Q2	$2.83M	Buy	25,085 +2,764	+12%	+$311K	0.13%	182
2021 Q1	$2.42M	Sell	22,321 -1,790	-7%	-$191K	0.13%	170
2020 Q4	$2.58M	Buy	24,111 +1,518	+7%	+$146K	0.14%	167
2020 Q3	$1.98M	Buy	22,593 +2,428	+12%	+$229K	0.16%	143
2020 Q2	$2.01M	Sell	20,165 -3,885	-16%	-$342K	0.19%	133
2020 Q1	$1.77M	Buy	24,050 +797	+3%	+$67.9K	0.16%	146
2019 Q4	$2.06M	Buy	23,253 +3,106	+15%	+$258K	0.15%	160
2019 Q3	$1.48M	Sell	20,147 -501	-2%	-$34.3K	0.11%	200
2019 Q2	$1.5M	Buy	20,648 +3,111	+18%	+$245K	0.11%	191
2019 Q1	$1.42M	Buy	17,537 +1,023	+6%	+$83.7K	0.12%	188
2018 Q4	$1.47M	Buy	+16,514	New	+$1.45M	0.13%	172
2018 Q2	–	Sell	-34,839	Closed	-$3.3M	–	144
2018 Q1	$3.3M	Buy	34,839 +16,338	+88%	+$1.79M	0.2%	104
2017 Q4	$1.79M	Buy	+18,501	New	+$1.74M	0.19%	126
2017 Q3	–	Sell	-27,740	Closed	-$2.01M	–	154
2017 Q2	$2.01M	Buy	+27,740	New	+$1.86M	0.29%	95
2016 Q3	–	Sell	-9,552	Closed	-$591K	–	161
2016 Q2	$591K	Buy	+9,552	New	+$582K	0.11%	115

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mariner Independent Advisor Network's ABBV Position: Q3 2022 in Review

Mariner Independent Advisor Network reduced its AbbVie (ABBV) stake by 4.5% in Q3 2022, selling an estimated $311K and leaving 45,968 shares worth $6.17M. The position accounts for 0.27% of the portfolio, ranked #88.

Mariner Independent Advisor Network first reported a position in ABBV in Q2 2016 and has held it in 20 quarters since. The position peaked at $7.35M in Q2 2022. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

Mariner Independent Advisor Network held 45,968 shares of AbbVie worth $6.17M as of Q3 2022.
Mariner Independent Advisor Network sold 2,164 AbbVie shares in Q3 2022, an estimated $311K.
AbbVie made up 0.27% of Mariner Independent Advisor Network's portfolio in Q3 2022, its #88 holding.
Mariner Independent Advisor Network first reported a position in AbbVie in Q2 2016 and has held it in 20 quarters since.
Mariner Independent Advisor Network's AbbVie position peaked at $7.35M in Q2 2022.
2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Mariner Independent Advisor Network's 13F filing for Q3 2022, filed 10 Nov 2022.